Clemow, David B.
Johnson, Kirk W.
Hochstetler, Helen M.
Ossipov, Michael H.
Hake, Ann M.
Blumenfeld, Andrew M.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 11 March 2020
Accepted: 25 May 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, and Ann M. Hake are employed by and are stockholders of Eli Lilly and Company. Michael H. Ossipov is employed by Evidera and owns some Lilly stock. Andrew M. Blumenfeld has received fees for consulting and promotional speaking from Eli Lilly and Company.